Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

Historically, neoadjuvant chemotherapy (NACT) was extrapolated from adjuvant regimens. Dual HER2 blockade and the introduction of carboplatin for triple negative breast cancers (TNBC) emerged by December 2013 and have improved pathological complete response (pCR) rates. The objective of this study w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Oncol
Main Authors: McFarland, Daniel C., Naikan, Jessica, Rozenblit, Mariya, Mandeli, John, Bleiweiss, Ira, Tiersten, Amy
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4921638/
https://ncbi.nlm.nih.gov/pubmed/27382369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4324863
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki